Unpacking Anti-Monopoly Law Enforcement in China
China Business Law Podcast
English - June 13, 2024 01:39 - 47 minutes - 43.2 MBManagement Business chinabusinesslaw chinabusinesslawpodcast chinalaw chinalawyer lawinchina Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Ying Song
https://www.linkedin.com/in/ying-song-66742526/
Iris Yuan
https://www.linkedin.com/in/irisjlyuan/
Art Dicker
https://www.linkedin.com/in/art-dicker/
Welcome to another enlightening episode of the China Business Law Podcast! In this episode, co-hosts Art Dicker and Iris Yuan sit down with a special guest, Song Ying, to delve into the intricate world of Anti-Monopoly Law (AML) enforcement in China. As an absolute expert in this field, Ying offers a comprehensive overview of current trends, key cases, and practical advice for companies navigating the complexities of AML.
Introduction to Song Ying
Ying is a leading authority on anti-monopoly law, currently an executive partner at AnJie, Ying brings a wealth of knowledge and experience to the podcast.
AML Enforcement in China: A Comparative OverviewYing kicks off the discussion by outlining the three main types of behaviors regulated under China's AML:
1. Monopoly Agreements: Horizontal and vertical agreements that restrict competition, such as price-fixing, market partitioning, and output restriction.
2. Abuse of Dominance: Actions by dominant companies that exploit their market position, including excessive pricing, exclusionary practices, and refusal to deal.
3. Merger Control: Pre-transaction filings required for large deals to prevent anti-competitive consolidations.
Ying emphasizes the differences between China's approach and that of the EU and the US, noting China's post-regulation stance for monopoly agreements and abuse of dominance, versus its pre-regulation approach for mergers.
Key Cases and Their ImpactThe Alibaba and Meituan CasesThese landmark cases highlight the hefty penalties imposed on tech giants for anti-competitive behaviors:
Alibaba: Fined approximately $2 billion for exclusive dealing practices.Meituan: Similarly penalized for restrictive dealings.Pharmaceutical Industry FocusYing notes a recent shift in enforcement priorities to the pharmaceutical sector, where excessive pricing and anti-competitive practices have drawn significant attention.
Hitachi Metals Case: A Landmark DecisionThe Hitachi Metals case serves as a crucial example of private enforcement actions. Chinese firms accused Hitachi of refusing to license essential patents, sparking a decade-long legal battle. The case underscored the delicate balance between IP rights and anti-monopoly regulations.
Gun-Jumping ConcernsCompanies must be cautious about pre-transaction behaviors that might violate AML provisions. Ying discusses recent stricter enforcement against gun-jumping and advises businesses to thoroughly assess their compliance strategies.
Practical Advice for CompaniesRisk ManagementTo mitigate AML risks, Ying advises companies to:
Collect evidence demonstrating market competition.Document price trends and market entries/exits.Prepare for potential third-party complaints and investigations.Global TransactionsYing underscores the importance of considering China's merger control regime for global deals. Foreign-to-foreign transactions are not exempt, and timely filings are crucial to avoid delays and hefty penalties.# Insights from the China Business Law Podcast: Unpacking Anti-Monopoly Law Enforcement in China
Welcome to another enlightening episode of the China Business Law Podcast! In this episode, co-hosts Art Dicker and Iris Yuan sit down with a special guest, Song Ying, to delve into the intricate world of Anti-Monopoly Law (AML) enforcement in China. As an absolute expert in this field, Ying offers a comprehensive overview of current trends, key cases, and practical advice for companies navigating the complexities of AML.
Timestamps
00:00 Introduction and Guest Welcome
00:29 Ying's Background and Expertise
03:19 Overview of China's Anti-Monopoly Law
03:52 Types of Regulated Behaviors
07:15 High-Profile Cases and Penalties
14:58 Pharmaceutical Sector Focus
30:54 Private Enforcement and Notable Cases
34:46 Conditional Approvals and Gun Jumping
ProducerFollow Us